换一批
换一批(Bortezomib plus lenalidomide/thalidomide)- vs. (bortezomib or lenalidomide/thalidomide)-containing regimens as induction therapy in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials.
作者：
主题词
抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);硼酸化物(Boronic Acids);人类(Humans);免疫抑制剂(Immunosuppressive Agents);多发性骨髓瘤(Multiple Myeloma);吡嗪类(Pyrazines);随机对照试验(主题)(Randomized Controlled Trials as Topic);缓解诱导(Remission Induction);沙立度胺(Thalidomide)
DOI
10.1007/s00277-012-1520-4
PMID
22773209
发布时间
2022-03-31
- 浏览35
Annals of hematology
1779-84页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
